key: cord-0306835-ej1p1p77
authors: Ranjan, R.
title: Omicron Impact in India: An Early Analysis of the Ongoing COVID-19 Third Wave
date: 2022-01-10
journal: nan
DOI: 10.1101/2022.01.09.22268969
sha: aff2200918a4698c63fd219d89f2550ea11a6dd0
doc_id: 306835
cord_uid: ej1p1p77

India is currently experiencing the third wave of COVID-19, which began on around 28 Dec. 2021. Although genome sequencing data of a sufficiently large sample is not yet available, the rapid growth in the daily number of cases, comparable to South Africa, United Kingdom, suggests that the current wave is primarily driven by the Omicron variant. The logarithmic regression suggests the growth rate of the infections during the early days in this wave is nearly four times than that in the second wave. Another notable difference in this wave is the relatively concurrent arrival of outbreaks in all the states; the effective reproduction number (Rt) although has significant variations among them. The test positivity rate (TPR) also displays a rapid growth in the last 10 days in several states. Preliminary estimates with the SIR model suggest that the peak to occur in late January 2022 with peak caseload exceeding that in the second wave. Although the Omicron trends in several countries suggest a decline in case fatality rate and hospitalizations compared to Delta, a sudden surge in active caseload can temporarily choke the already stressed healthcare India is currently experiencing the third wave of COVID-19, which began on around 28 Dec. 2021. Although genome sequencing data of a sufficiently large sample is not yet available, the rapid growth in the daily number of cases, comparable to South Africa, United Kingdom, suggests that the current wave is primarily driven by the Omicron variant. The logarithmic regression suggests the growth rate of the infections during the early days in this wave is nearly four times than that in the second wave. Another notable difference in this wave is the relatively concurrent arrival of outbreaks in all the states; the effective reproduction number (Rt) although has significant variations among them. The test positivity rate (TPR) also displays a rapid growth in the last 10 days in several states. Preliminary estimates with the SIR model suggest that the peak to occur in late January 2022 with peak caseload exceeding that in the second wave. Although the Omicron trends in several countries suggest a decline in case fatality rate and hospitalizations compared to Delta, a sudden surge in active caseload can temporarily choke the already stressed healthcare infrastructure. Therefore, it is advisable to strictly adhere to COVID-19 appropriate behavior for the next few weeks to mitigate an explosion in the number of infections.

The world experienced devastating COVID-19 waves in 2021 which were primarily driven by the Delta or B.1.617 variant of the deadly SARS-CoV-2 virus. This variant was not only twice more infectious than its earlier predecessors (Alpha, Beta) but also caused serious illness and causalities[1] especially to those who were not vaccinated. Towards the end of 2021, when the delta variant was continuing to create havoc in several regions of the world, a new variant B.1.1.529 or 'Omicron' was detected in South Africa. Soon it was declared as a variant of concern (VOC) by WHO on Nov. 26, 2021, due to several mutations, including 15 mutations in the receptor-binding domain (RBD) of spike protein [2] , as well as increased transmissibility [3, 4, 5] . Omicron quickly replaced the Delta strain in SA to give a new peak of more than 37000 cases compared to 26000 in all the previous waves.

By the end of 2021, Omicron spread to more than 50 countries including the United Kingdom, the United States, France, Italy, Netherlands, and India causing new waves. The worldwide daily number of infections shot to about 2.8 million on Jan. 7, 2022, compared to the highest peak of about 0.7 million prior to Omicron. The US alone had reported more than 1 million cases on Jan. 4, 2022 . Several studies [6, 3, 2] have raised concern about Omicron evading the antibodies thus increasing the chances of reinfection as well as breakthrough infections. Recent research [7] suggests that three doses of mRNA-based vaccines may also not be sufficient to prevent infection and symptomatic disease with the Omicron variant. However, studies [3, 2] also indicate a reduction of severity of COVID-19 due to vaccination, and clinical manifestations of mild to moderate form of COVID-19. This may significantly help in reducing hospitalizations and deaths despite a large number of infections. Another silver lining is that the early data [8] suggests Omicron infections may be milder compared to earlier variants.

This study concerns the analysis of spatio-temporal dynamics of the ongoing third wave in India, which appears to be driven by the Omicron variant, although large-scale genome sequencing to ascertain this is yet to be done. This wave began on Dec. 28, 2021, nearly six months after the onset of the second wave. Figure 1 shows different waves of COVID-19 infection that India has observed since the beginning of the pandemic in early 2020. The peak cases in the first and second waves were about 0.1 and 0.4 million respectively. Also, the growth curve in the second wave was much steeper than the first wave. At the time of writing the current manuscript, it is about 10 days into the third wave, but daily cases increased from 6,340 on Dec. 27, 2021 to 1,60,610 on Jan. 08, 2022 -a 25 fold increase in 13 days. The curve for the third wave is therefore steeper than the second wave-a characteristic of the outbreaks driven by Omicron as seen in several other countries (e.g. SA, UK, France, Italy and US).

India has a nearly 1.3 billion population and about 0.9 billion population is vaccinated with at least one dose. Further, India has seen a devastating second wave due to the Delta variant, and therefore there is significant interest in the possible course and consequences of the current wave. Unavailability of detailed Omicron characteristics such as its pathogenicity also adds to uncertainty and anxiety. The present study focuses on the characterization of this wave: intensity, severity, regional variations, the possible future course of the pandemic, etc., purely from the perspective of data. The growth curve in the current wave is compared against those of the Omicron-affected countries which 2 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 10, 2022. ; https://doi.org/10.1101/2022.01.09.22268969 doi: medRxiv preprint Figure 1 : COVID-19 waves in India. The first and second waves as well as the onset of the third wave are shown. Arrows with δ and O indicate pandemic to be primarily driven by Delta and Omicron variants respectively. The dominance of Omicron in the third wave will be established later.

are ahead of India in terms of onset. This helps establish whether the current wave is due to the spread of Omicron.

Further, the available data is used to estimate the exponential growth rate, effective reproduction number [9] , test positivity rate (TPR). Regional variations in the wave are also investigated. Finally, an epidemiological model is used to make projections about peak and eventual decay. Throughout the study, the parameters obtained from the current wave are compared against those in the second wave with the objective of creating awareness among people and other stakeholders.

The present study is based on COVID-19 time-series data from the beginning of the pandemic to Jan. 8, 2022.

These data are taken from several sources: 1) ourworldindata (OWID; [10] ) for all the countries, 2) covid19india.org (COVID19INDIA; [11] and covid19tracker.in (COVID19TRACKER; [12] for India and her states. Unless mentioned otherwise, a 7-day rolling average of daily data was taken for computation of all the parameters as well as modeling.

We first discuss the intensity of the ongoing third wave in India and compare it to that in Omicron-affected countries.

This comparison is also used to ascertain whether the current wave in India is primarily driven by the Omicron variant. Figure 2 shows the increase in cases in the first 11 days of the Omicron in six countries. Since the beginning of the 3 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 10, 2022. ; https://doi.org/10.1101/2022.01.09.22268969 doi: medRxiv preprint Figure 2 : The intensity of the Omicron outbreak in 6 affected countries including India during the first 11 days of the spread. Exponential fits are used to estimate the growth rate. Markers show the actual number of cases, while the lines show the exponential fits. Table 1 presents the exponential factors as obtained from the fit. The onset date of wave for this plot is also included in the table.

wave is characterized by exponential growth, we plot the number of cases on logscale. All the countries exhibit nearly similar growth in the initial days. This trend suggests the predominant SARS CoV-2 Omnicron variant accounts for a large proportion of the cases in the current wave in India. Further, it is expected that like SA and other regions, Omicron will soon replace the Delta variant.

To further quantify, we employ exponential fits as shown by lines in Fig. 2 . The parameters of these fits are given in Table 1 . A key observation is that the growth rate, given by parameter r in the fit I(t) = I 0 exp(rt), is nearly similar ( 0.18) in the US, UK, France, and Italy as also seen in Fig. 2 . India has a slightly higher initial growth rate with r 0.28 which is comparable to that in SA. When compared to the second wave in India, as discussed in [13] , this factor is nearly four times higher. Based on these rates, doubling time during the exponential growth phase in this wave is about 2.5 days compared to about 10 days in the second wave. Table 1 also lists key goodness of fit parameters. All the fits have a high value of the coefficient of determination (R 2 ≥ 0.97).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 10, 2022. 

Next, we discuss the regional variations in the local outbreaks. During the second wave, large differences were seen in The TPR in India dramatically increased tenfold in 12 days, from 0.75% on Dec. 27, 2021, to 7.5% on Jan. 8, 2022. As per the latest data, the TPR for West Bengal is alarmingly high (>25%), while Delhi and Maharashtra also have TPR greater than 15%. Table 2 lists the TPR of all the states in India. Goa (21%), Punjab(11%), Chandigarh(13%), and

Mizoram (11%) also have very high TPRs. A sudden surge in cases due to the high transmissibility of Omicron has caused a dramatic increase in TPR in all the regions it has impacted. For example, the US currently has a TPR of about 25%.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 10, 2022. We next discuss another key metric, the effective reproduction number or R t , that represents the average number of infections caused by a single infected individual. Unlike the basic reproduction number or R 0 which is typically fixed for a given outbreak, R t provides temporal variations in the virus transmissibility and hence accounts for temporary interventions, spread, etc. R t > 1 indicates growth in infection. Time-varying R t is calculated using time-series data of the infections and generation time distribution [14, 15] . We use the approach developed by Thompson et al. [16] and details are given in [13] . Figure 4 provides the variations of daily cases (incidence) and R t computed from this data for 15 states; the latest R t for all the states and populated union territories are listed in Table 2 . The effective reproduction number trend typically follows the infection rate curve but reveals transmissibility that may provide insights into the potential future course of the pandemic. A key observation from the figure is the sharp rise in the R t value in all the states except Kerala since the onset of the third wave, although there is a larger uncertainty in the computation of R t in the beginning of a wave [17] . Most states have exceeded the peak R t value in the second wave. The trends suggest that daily cases are going to increase rapidly in the next few days before the arrival of the peak which will be discussed later. Another notable observation Table 2 is that the third wave has arrived relatively simultaneously in all the states with R t value greater than the threshold value of 1 for all the regions. This is in contrast to the first and second waves when there was a significant gap of a few weeks to a couple of months in the onset of wave in different states .

6 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 10, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 10, 2022. ; https://doi.org/10.1101/2022.01.09.22268969 doi: medRxiv preprint Figure 4 : Temporal variations of the effective reproduction number (R t ) along with incidence (daily infections) data for 15 most-impacted states. The onset of the third wave corresponds with the most recent date when R t crossed the threshold of 1.0.

8 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 10, 2022. ; https://doi.org/10.1101/2022.01.09.22268969 doi: medRxiv preprint It has been established by the growth curves that there is a high level of community transmissions in the current wave compared to earlier waves. Now we discuss the potential severity of cases in this wave in contrast to earlier waves.

Early studies suggest that Omicron infections might be less severe than other variants [8] , however more virological data is needed to ascertain this. We rely on time-series data-based approach to gather some insights on the possible impact of Omicron on severe infections and fatality.

Since it has been only two weeks into the third wave, we will employ insights from other Omicron-affected countries to make informed estimates. In order to extrapolate the data from these countries to India, we need to compare the vaccination levels. As alluded earlier, it has been found [7] that Omicron can evade neutralizing antibodies, obtained either from the vaccination or natural infection, and thus there is a greater probability of breakthrough infections. workers as well as 60+ populations with co-morbidities. Results from South Africa suggest higher hospitalization rates in Omicron among children compared to earlier waves, probably due to lower levels of pre-existing immunity [18] .

Until Jan 3, India had only 18+ adults eligible for the vaccination. Following the onset of the third wave, India recently started vaccinations for 15+ eligible populations. Now, we discuss parameters related to the severity of Omicron infections as found in different regions. Figure 5 shows the daily cases, daily case fatality rate (CFR), and weekly case hospitalization rate (CHR) for five Omicron-impacted countries. The case fatality rate is defined as the ratio between confirmed deaths and confirmed cases 10 days earlier as the fatality lags the cases roughly by 10 days [10] . The case hospitalization rate is introduced as a new metric, which is defined as the ratio between weekly new hospitalizations and weekly confirmed cases. Although there is a difference of a few days before Omicron spread into these regions, for simplicity we take Dec. 1, 2021 as the date when trends became visible. The CFRs of all the countries exhibit a decreasing trend in the Omicron wave. SA saw a drastic decay of CFR from about 10% (not visible in fig.) on Nov. 26, 2021, to less than 1% on Jan. 28, 2021. Also, in the US, the UK, France, and Italy, the CFR is less than 1% based on the latest data. Although it remains to be seen if the trend persists.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 10, 2022. ; https://doi.org/10.1101/2022.01.09.22268969 doi: medRxiv preprint Next, we discuss the hospitalization rate from the countries where the weekly hospital admission data due to COVID-19 is available. Once again the CHR curve shows a decreasing trend during the most recent wave. The UK, France, and Italy show less than 3 hospital admissions per 100 infections in the most recent week. The US has slightly higher than 5% CHR. In the last week, both France and the US have shown a slight increase in CHR. This relatively low CHR is also expected to be characteristics of the third wave in India. The low CHR will also consequently improve the case recovery rate (CRR) and thus accelerating the decline of the wave following the peak. This will be further discussed in the next section. These factors overall suggest that the severity of the third wave will be lesser than the second wave despite high community transmission.

After characterization, we employ an epidemiological model on the third wave data to make useful estimates on the possible progression of the pandemic. Specifically, we employ the dynamical SIR model [19] , which takes both the incidence and recovery data to estimate the peak as well as the eventual decline of the pandemic. The author has successfully used this model to make projections of the course of pandemic in the second COVID-19 wave. Both the peak caseload as well as date were reasonably well-predicted by this model in advance of about a month from the peak.

Obtaining reliable estimates for the third wave is more challenging because of the expected very sharp rise and decay of the wave (based on observations from SA and UK) and thus leaving a very small window size for the input data.

However, it is expected that the estimates will be useful in policy-making decisions if not quantitatively precise.

We employ the MATLAB implementation of the SIR model as developed by [20] . This model is tweaked for the Indian data as delineated in [13] . Figure 6 shows the predictions for India using the SIR model along with other key characterizing metrics discussed earlier. The input data used for the projection is taken between 27 Dec. 2021 and 5 Jan. 2022. Statewise and districtwise estimates for most affected regions are available on our website www.covid19-forecast.org. According to the model (top panel in Fig. 6 ) based on about 10 days of data, the third wave is expected to peak around the third week of January. Therefore, the period of the wave will be much shorter than the earlier waves. The second wave took about three months (mid-Feb to mid-May) to peak. Despite a short period, the peak caseload in the current wave (> 0.4 million) could be similar to that of the second wave. This rapid surge in numbers could stress the healthcare systems in the coming weeks, despite the low CHR.

The model also suggests a rapid decline in the number of cases following the peak. This is commensurate with our earlier observation of a relatively high case recovery rate (CRR) in the current wave. High CRR may also ease the burden of active caseload compared to the second wave. The peak in active cases is expected to come about two weeks following the peak in daily infections. The peak in daily fatalities should follow the peak in active cases. The rapid increase in the number of cases needs to match with a proportional increase in the daily testing capacity in order to keep the test positivity rate (TPR) to the recommended level of less than 5%. Further, since the current wave has arrived 10 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 10, 2022. ; https://doi.org/10.1101/2022.01.09.22268969 doi: medRxiv preprint Figure 5 : Temporal variations of daily cases, Case fatality rate (CFR), and Case Hospitalization rate (wherever available) in five Omicron-impacted countries. The most recent wave with Omicron is marked with a right arrow on the top right. Note that, y-axis in top panels are truncated to focus on the regions of interest.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 10, 2022. ; https://doi.org/10.1101/2022.01.09.22268969 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 10, 2022. ; https://doi.org/10.1101/2022.01.09.22268969 doi: medRxiv preprint relatively simultaneously in all the states, this may restrict the mobilization of patients and resources across the states to some level.

Despite indications from the model about rapid growth and rapid decline of cases along with fewer hospitalizations and deaths compared to the second wave, a major concern is the emergence of a new variant due to high community transmission. This may alter the course of the pandemic and characterization of the new variant needs to be conducted.

Hence, it is suggested to follow concurrent prevention strategies including social distancing, masking, vaccination, testing, and quarantine to avoid new mutations as well as hospital loads.

• The intensity of infection and transmission in the third wave is significantly higher than the second wave.

• The early trend of daily cases in India compares well with the early trend data of other Omicron-affected countries (SA, US, UK, Italy, France), thus indicating that the third wave is predominantly driven by Omicron.

• Signs of the third wave are visible across every state and union territory in India. This contrasts with the second wave when the onsets were offset by a few weeks to months.

• Based on data from other Omicron-affected countries, despite high transmission, hospitalizations and fatalities per infection are expected to be lower.

• Preliminary analysis with the SIR model suggests a peak within a month of the onset of the third wave. The decline is also expected to be faster than the second wave.

The author would like to thank Prof. Mahendra K. Verma for the insightful discussions. Acknowledgments are also due to Dr. Sudheendra Rao N R, Dr. Deepti Chugh for discussions at various points. Mr. Aryan Sharma and Mr. Rahul Garg provided help with plots and other material on our COVID-19 website.

All the data that support the findings of this study are publicly available.

[1] Katherine A Twohig, Tommy Nyberg, Asad Zaidi, Simon Thelwall, Mary A Sinnathamby, Shirin Aliabadi, Shaun R Seaman, Ross J Harris, Russell Hope, Jamie Lopez-Bernal, et al. Hospital admission and emergency care attendance risk for sars-cov-2 delta (b. 1.617. 2) compared with alpha (b. 1.1. 7) variants of concern: a cohort study. The Lancet Infectious Diseases, 2021.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 10, 2022. ; https://doi.org/10.1101/2022.01.09.22268969 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 10, 2022. ; https://doi.org/10.1101/2022.01.09.22268969 doi: medRxiv preprint

Sars-cov-2 omicron variant: characteristics and prevention

Omicron sars-cov-2 variant: a new chapter in the covid-19 pandemic

How bad is omicron? what scientists know so far

Outbreak caused by the sars-cov-2 omicron variant in norway

Sars-cov-2 omicron strain exhibits potent capabilities for immune evasion and viral entrance

Breakthrough infections with sars-cov-2 omicron variant despite booster dose of mrna vaccine

Covid-19: Early studies give hope omicron is milder than other variants

Estimating effective reproduction number using generation time versus serial interval, with application to Covid-19 in the greater toronto area

Characterization of the second wave of covid-19 in india

A new framework and software to estimate time-varying reproduction numbers during epidemics

Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures

Improved inference of time-varying reproduction numbers during infectious disease outbreaks

Practical considerations for measuring the effective reproductive number, r t

How severe are omicron infections

Infectious diseases of humans: dynamics and control

Estimation of the final size of the COVID-19 epidemic. medRxiv